IN161992B - - Google Patents
Info
- Publication number
- IN161992B IN161992B IN1282/CAL/83A IN1282CA1983A IN161992B IN 161992 B IN161992 B IN 161992B IN 1282CA1983 A IN1282CA1983 A IN 1282CA1983A IN 161992 B IN161992 B IN 161992B
- Authority
- IN
- India
Links
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43515482A | 1982-10-19 | 1982-10-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN161992B true IN161992B (enrdf_load_stackoverflow) | 1988-03-12 |
Family
ID=23727220
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1282/CAL/83A IN161992B (enrdf_load_stackoverflow) | 1982-10-19 | 1983-10-19 |
Country Status (4)
| Country | Link |
|---|---|
| JP (4) | JPS5993093A (enrdf_load_stackoverflow) |
| IL (1) | IL90047A (enrdf_load_stackoverflow) |
| IN (1) | IN161992B (enrdf_load_stackoverflow) |
| ZA (1) | ZA837789B (enrdf_load_stackoverflow) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL76360A0 (en) | 1984-09-26 | 1986-01-31 | Takeda Chemical Industries Ltd | Mutual separation of proteins |
| JP2675294B2 (ja) * | 1984-10-15 | 1997-11-12 | カイロン コーポレイション | ヒト腫瘍壊死因子 |
| FI862531A0 (fi) * | 1984-10-15 | 1986-06-13 | Cetus Corp | Tumoernekrosisfaktor. |
| US4572798A (en) * | 1984-12-06 | 1986-02-25 | Cetus Corporation | Method for promoting disulfide bond formation in recombinant proteins |
| JP2721854B2 (ja) * | 1984-12-21 | 1998-03-04 | 大塚製薬株式会社 | 抗腫瘍活性物質 |
| JP2583753B2 (ja) * | 1984-12-21 | 1997-02-19 | 大塚製薬株式会社 | 抗腫瘍活性物質およびその製造法 |
| EP0199574B1 (en) * | 1985-04-22 | 1991-10-23 | Genentech, Inc. | Human tissue plasminogen activator mutants, methods and intermediates therefor, and compositions using such mutants |
| US4818698A (en) * | 1985-08-23 | 1989-04-04 | Toyo Jozo Co., Ltd. | Polypeptides and preparation process thereof |
| NZ226543A (en) * | 1987-10-22 | 1992-02-25 | Merck & Co Inc | Recombinant mutant acidic fibroblast growth factor |
| ES2085329T3 (es) * | 1989-02-17 | 1996-06-01 | Merck & Co Inc | Agente anticanceroso proteico. |
| IL93723A (en) * | 1989-03-22 | 1997-02-18 | Merck & Co Inc | Cystein modified truncated pseudomonas exotoxin A |
| US6207798B1 (en) | 1989-08-03 | 2001-03-27 | Merck & Co., Inc. | Modified PE40 toxin fusion proteins |
| JPH0751621A (ja) * | 1993-08-12 | 1995-02-28 | Kansei Kogyo Kk | 静電吸着による管内面更生工法 |
| AR034749A1 (es) * | 2001-07-09 | 2004-03-17 | Schering Ag | Formulaciones de interferon beta humano |
| US20050008616A1 (en) * | 2003-07-11 | 2005-01-13 | Schering Aktiengesellschaft | Recombinant human interferon-beta-1b polypeptides |
| CN116075523A (zh) * | 2020-04-29 | 2023-05-05 | 基因制药株式会社 | 具有融合的干扰素-β突变蛋白和抗体的重组蛋白以及包含其的药物组合物 |
-
1983
- 1983-10-14 IL IL90047A patent/IL90047A/xx not_active IP Right Cessation
- 1983-10-19 JP JP58195931A patent/JPS5993093A/ja active Granted
- 1983-10-19 IN IN1282/CAL/83A patent/IN161992B/en unknown
- 1983-10-19 ZA ZA837789A patent/ZA837789B/xx unknown
-
1984
- 1984-09-08 JP JP18730384A patent/JPS6128384A/ja active Granted
- 1984-09-08 JP JP18730484A patent/JPS6128394A/ja active Pending
- 1984-09-08 JP JP18730284A patent/JPS6128393A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0380475B2 (enrdf_load_stackoverflow) | 1991-12-25 |
| JPS5993093A (ja) | 1984-05-29 |
| IL90047A (en) | 1992-12-01 |
| ZA837789B (en) | 1984-11-28 |
| JPS6128384A (ja) | 1986-02-08 |
| JPS6357440B2 (enrdf_load_stackoverflow) | 1988-11-11 |
| JPS6128393A (ja) | 1986-02-08 |
| JPS6128394A (ja) | 1986-02-08 |
| JPH057996B2 (enrdf_load_stackoverflow) | 1993-01-29 |